NextCure, Inc. NXTC
NASDAQ · United States · Health Technology
$5.09+0.13 (+2.62%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -2.80 | -1.95 | -43.6% | $0 | — | +11.2%$5.25→$5.84 |
| Q1 2026 | 2026-05-07 | -1.87 | -1.85 | -1.1% | — | — | -9.0%$10.72→$9.76 |
| Q4 2025 | 2026-03-05 | -0.81 | -2.29 | +64.6% | — | — | -1.7%$12.60→$12.39 |
| Q3 2025 | 2025-11-05 | -3.22 | -4.06 | +20.7% | — | — | +1.9%$9.64→$9.82 |
| Q4 2024 | 2025-03-06 | -4.92 | -4.32 | -13.9% | — | — | — |
| Q4 2023 | 2024-03-21 | -6.24 | -6.52 | +4.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.